{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:31:42Z","timestamp":1790800302425,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["755\/19"],"award-info":[{"award-number":["755\/19"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alzheimer\u2019s disease (AD) is characterized by toxic protein accumulation in the brain. Ubiquitination is essential for protein clearance in cells, making altered ubiquitin signaling crucial in AD development. A defective variant, ubiquitin B\u2009+\u20091 (UBB\n                    <jats:sup>+1<\/jats:sup>\n                    ), created by a non-hereditary RNA frameshift mutation, is found in all AD patient brains post-mortem. We now detect UBB\n                    <jats:sup>+1<\/jats:sup>\n                    in human brains during early AD stages. Our study employs a 3D neural culture platform derived from human neural progenitors, demonstrating that UBB\n                    <jats:sup>+1<\/jats:sup>\n                    alone induces extracellular amyloid-\u03b2 (A\u03b2) deposits and insoluble hyperphosphorylated tau aggregates. UBB\n                    <jats:sup>+1<\/jats:sup>\n                    competes with ubiquitin for binding to the deubiquitinating enzyme UCHL1, leading to elevated levels of amyloid precursor protein (APP), secreted A\u03b2 peptides, and A\u03b2 build-up. Crucially, silencing UBB\n                    <jats:sup>+1<\/jats:sup>\n                    expression impedes the emergence of AD hallmarks in this model system. Our findings highlight the significance of ubiquitin signalling as a variable contributing to AD pathology and present a nonclinical platform for testing potential therapeutics.\n                  <\/jats:p>","DOI":"10.1038\/s41467-023-41545-7","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T10:02:41Z","timestamp":1695376961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Altered ubiquitin signaling induces Alzheimer\u2019s disease-like hallmarks in a three-dimensional human neural cell culture model"],"prefix":"10.1038","volume":"14","author":[{"given":"Inbal","family":"Maniv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahasen","family":"Sarji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Bdarneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alona","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roi","family":"Ankawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elle","family":"Koren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbar","family":"Magid-Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Soteriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiran","family":"Salomon-Zimri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Lavy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellina","family":"Kesselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naama","family":"Koifman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0700-6993","authenticated-orcid":false,"given":"Thimo","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3091-7154","authenticated-orcid":false,"given":"Oded","family":"Kleifeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Michaelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred W.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert M.","family":"Verheijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4391-9386","authenticated-orcid":false,"given":"Yaron","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1222-8104","authenticated-orcid":false,"given":"Michael H.","family":"Glickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"41545_CR1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/brain\/awad005","volume":"146","author":"R Perneczky","year":"2023","unstructured":"Perneczky, R. et al. Anti-amyloid antibody therapies in Alzheimer\u2019s disease. Brain: J. Neurol. 146, 842\u2013849 (2023).","journal-title":"Brain: J. Neurol."},{"key":"41545_CR2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper, B. & Karran, E. The cellular phase of Alzheimer\u2019s disease. Cell 164, 603\u2013615 (2016).","journal-title":"Cell"},{"key":"41545_CR3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Prim. 7, 33 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"41545_CR4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.psc.2022.07.003","volume":"45","author":"BC Yarns","year":"2022","unstructured":"Yarns, B. C., Holiday, K. A., Carlson, D. M., Cosgrove, C. K. & Melrose, R. J. Pathophysiology of Alzheimer\u2019s disease. Psychiatr. Clin. North Am. 45, 663\u2013676 (2022).","journal-title":"Psychiatr. Clin. North Am."},{"key":"41545_CR5","doi-asserted-by":"crossref","first-page":"2756068","DOI":"10.1155\/2016\/2756068","volume":"2016","author":"A Tramutola","year":"2016","unstructured":"Tramutola, A., Di Domenico, F., Barone, E., Perluigi, M. & Butterfield, D. A. It is all about (U)biquitin: role of altered ubiquitin-proteasome system and UCHL1 in Alzheimer disease. Oxid. Med. Cell Longev. 2016, 2756068 (2016).","journal-title":"Oxid. Med. Cell Longev."},{"key":"41545_CR6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1515\/revneuro-2017-0013","volume":"28","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., Chen, X., Zhao, Y., Ponnusamy, M. & Liu, Y. The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer\u2019s disease. Rev. Neurosci. 28, 861\u2013868 (2017).","journal-title":"Rev. Neurosci."},{"key":"41545_CR7","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1089\/ars.2013.5802","volume":"21","author":"C McKinnon","year":"2014","unstructured":"McKinnon, C. & Tabrizi, S. J. The ubiquitin-proteasome system in neurodegeneration. Antioxid. Redox Signal 21, 2302\u20132321 (2014).","journal-title":"Antioxid. Redox Signal"},{"key":"41545_CR8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","volume":"82","author":"MH Glickman","year":"2002","unstructured":"Glickman, M. H. & Ciechanover, A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82, 373\u2013428 (2002).","journal-title":"Physiol. Rev."},{"key":"41545_CR9","doi-asserted-by":"crossref","first-page":"eabk2252","DOI":"10.1126\/sciadv.abk2252","volume":"8","author":"ES Chocron","year":"2022","unstructured":"Chocron, E. S. et al. Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer\u2019s-like pathology in mouse and fly APP overexpression models. Sci. Adv. 8, eabk2252 (2022).","journal-title":"Sci. Adv."},{"key":"41545_CR10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.279.5348.242","volume":"279","author":"FW van Leeuwen","year":"1998","unstructured":"van Leeuwen, F. W. et al. Frameshift mutants of beta-amyloid precursor protein and ubiquitin-B in Alzheimer\u2019s and down patients. Science 279, 242\u2013247 (1998).","journal-title":"Science"},{"key":"41545_CR11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nchembio.1574","volume":"10","author":"D Krutauz","year":"2014","unstructured":"Krutauz, D. et al. Extended ubiquitin species are protein-based DUB inhibitors. Nat. Chem. Biol. 10, 664\u2013670 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"41545_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fnmol.2015.00047","volume":"8","author":"RJ Gentier","year":"2015","unstructured":"Gentier, R. J. & van Leeuwen, F. W. Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer\u2019s disease. Front Mol. Neurosci. 8, 47 (2015).","journal-title":"Front Mol. Neurosci."},{"key":"41545_CR13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/wsbm.1340","volume":"8","author":"X Chen","year":"2016","unstructured":"Chen, X. & Petranovic, D. Role of frameshift ubiquitin B protein in Alzheimer\u2019s disease. Wiley Interdiscip. Rev. Syst. Biol. Med. 8, 300\u2013313 (2016).","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"41545_CR14","doi-asserted-by":"crossref","first-page":"105361","DOI":"10.1016\/j.neuint.2022.105361","volume":"158","author":"N Watamura","year":"2022","unstructured":"Watamura, N., Sato, K. & Saido, T. C. Mouse models of Alzheimer\u2019s disease for preclinical research. Neurochem. Int. 158, 105361 (2022).","journal-title":"Neurochem. Int."},{"key":"41545_CR15","doi-asserted-by":"crossref","first-page":"e110002","DOI":"10.15252\/embj.2021110002","volume":"41","author":"L Aerts","year":"2022","unstructured":"Aerts, L. et al. Do we still need animals? Surveying the role of animal-free models in Alzheimer\u2019s and Parkinson\u2019s disease research. EMBO J. 41, e110002 (2022).","journal-title":"EMBO J."},{"key":"41545_CR16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.neurobiolaging.2014.10.025","volume":"36","author":"CE Finch","year":"2015","unstructured":"Finch, C. E. & Austad, S. N. Commentary: is Alzheimer\u2019s disease uniquely human? Neurobiol. aging 36, 553\u2013555 (2015).","journal-title":"Neurobiol. aging"},{"key":"41545_CR17","doi-asserted-by":"crossref","first-page":"103568","DOI":"10.1016\/j.mcn.2020.103568","volume":"110","author":"G Cenini","year":"2021","unstructured":"Cenini, G. et al. Dissecting Alzheimer\u2019s disease pathogenesis in human 2D and 3D models. Mol. Cell Neurosci. 110, 103568 (2021).","journal-title":"Mol. Cell Neurosci."},{"key":"41545_CR18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13195-017-0268-4","volume":"9","author":"C Arber","year":"2017","unstructured":"Arber, C., Lovejoy, C. & Wray, S. Stem cell models of Alzheimer\u2019s disease: progress and challenges. Alzheimer\u2019s Res. Ther. 9, 42 (2017).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"41545_CR19","volume":"11","author":"SH Choi","year":"2016","unstructured":"Choi, S. H., Kim, Y. H., Quinti, L., Tanzi, R. E. & Kim, D. Y. 3D culture models of Alzheimer\u2019s disease: a road map to a \u201ccure-in-a-dish\u201d. Mol. Neurodegener. 11, 75 (2016).","journal-title":"Mol. Neurodegener."},{"key":"41545_CR20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nature13800","volume":"515","author":"SH Choi","year":"2014","unstructured":"Choi, S. H. et al. A three-dimensional human neural cell culture model of Alzheimer\u2019s disease. Nature 515, 274\u2013278 (2014).","journal-title":"Nature"},{"key":"41545_CR21","doi-asserted-by":"crossref","first-page":"bio056796","DOI":"10.1242\/bio.056796","volume":"10","author":"OJ Olajide","year":"2021","unstructured":"Olajide, O. J., Suvanto, M. E. & Chapman, C. A. Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer\u2019s disease. Biol. open 10, bio056796 (2021).","journal-title":"Biol. open"},{"key":"41545_CR22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","volume":"109","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Strickland, M. R., Soranno, A. & Holtzman, D. M. Apolipoprotein E: structural Insights and Links to Alzheimer disease pathogenesis. Neuron 109, 205\u2013221 (2021).","journal-title":"Neuron"},{"key":"41545_CR23","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","volume":"110","author":"YA Martens","year":"2022","unstructured":"Martens, Y. A. et al. ApoE cascade hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias. Neuron 110, 1304\u20131317 (2022).","journal-title":"Neuron"},{"key":"41545_CR24","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin, A. C. et al. ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol. Neurodegener. 17, 72 (2022).","journal-title":"Mol. Neurodegener."},{"key":"41545_CR25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat. Med. 24, 647\u2013657 (2018).","journal-title":"Nat. Med."},{"key":"41545_CR26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi, Y. et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523\u2013527 (2017).","journal-title":"Nature"},{"key":"41545_CR27","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-8-16","volume":"8","author":"O Liraz","year":"2013","unstructured":"Liraz, O., Boehm-Cagan, A. & Michaelson, D. M. ApoE4 induces Abeta42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice. Mol. Neurodegeneration 8, 16 (2013).","journal-title":"Mol. Neurodegeneration"},{"key":"41545_CR28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1101\/lm.030031.112","volume":"20","author":"GA Rodriguez","year":"2013","unstructured":"Rodriguez, G. A., Burns, M. P., Weeber, E. J. & Rebeck, G. W. Young APOE4 targeted replacement mice exhibit poor spatial learning and memory, with reduced dendritic spine density in the medial entorhinal cortex. Learn. Mem. 20, 256\u2013266 (2013).","journal-title":"Learn. Mem."},{"key":"41545_CR29","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nprot.2015.065","volume":"10","author":"YH Kim","year":"2015","unstructured":"Kim, Y. H. et al. A 3D human neural cell culture system for modeling Alzheimer\u2019s disease. Nat. Protoc. 10, 985\u20131006 (2015).","journal-title":"Nat. Protoc."},{"key":"41545_CR30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1083\/jcb.200111034","volume":"157","author":"K Lindsten","year":"2002","unstructured":"Lindsten, K. et al. Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation. J. Cell Biol. 157, 417\u2013427 (2002).","journal-title":"J. Cell Biol."},{"key":"41545_CR31","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41380-019-0410-8","volume":"25","author":"C Arber","year":"2020","unstructured":"Arber, C. et al. Familial Alzheimer\u2019s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta. Mol. psychiatry 25, 2919\u20132931 (2020).","journal-title":"Mol. psychiatry"},{"key":"41545_CR32","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson, O. Biomarkers for neurodegenerative diseases. Nat. Med. 27, 954\u2013963 (2021).","journal-title":"Nat. Med."},{"key":"41545_CR33","volume":"11","author":"SS Kwak","year":"2020","unstructured":"Kwak, S. S. et al. Amyloid-beta42\/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer\u2019s disease. Nat. Commun. 11, 1377 (2020).","journal-title":"Nat. Commun."},{"key":"41545_CR34","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.nbd.2017.06.005","volume":"106","author":"P Reilly","year":"2017","unstructured":"Reilly, P. et al. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation. Neurobiol. Dis. 106, 222\u2013234 (2017).","journal-title":"Neurobiol. Dis."},{"key":"41545_CR35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick, A. W. P. et al. Cryo-EM structures of tau filaments from Alzheimer\u2019s disease. Nature 547, 185\u2013190 (2017).","journal-title":"Nature"},{"key":"41545_CR36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","volume":"598","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Structure-based classification of tauopathies. Nature 598, 359\u2013363 (2021).","journal-title":"Nature"},{"key":"41545_CR37","doi-asserted-by":"crossref","first-page":".0247","DOI":"10.1523\/ENEURO.0247-22.2022","volume":"9","author":"M Huang","year":"2022","unstructured":"Huang, M. et al. Increase in tau pathology in P290S mapt knock-in mice crossed with app (NL-G-F) mice. eNeuro 9, .0247\u201322.2022 (2022).","journal-title":"eNeuro"},{"key":"41545_CR38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","volume":"561","author":"B Falcon","year":"2018","unstructured":"Falcon, B. et al. Structures of filaments from Pick\u2019s disease reveal a novel tau protein fold. Nature 561, 137\u2013140 (2018).","journal-title":"Nature"},{"key":"41545_CR39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He, Z. et al. Amyloid-beta plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat. Med. 24, 29\u201338 (2018).","journal-title":"Nat. Med."},{"key":"41545_CR40","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"GF Chen","year":"2017","unstructured":"Chen, G. F. et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharm. Sin. 38, 1205\u20131235 (2017).","journal-title":"Acta Pharm. Sin."},{"key":"41545_CR41","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.3390\/ijms21145149","volume":"21","author":"CO Wong","year":"2020","unstructured":"Wong, C. O. Endosomal-lysosomal processing of neurodegeneration-associated proteins in astrocytes. Int J. Mol. Sci. 21, 5149 (2020).","journal-title":"Int J. Mol. Sci."},{"key":"41545_CR42","doi-asserted-by":"crossref","DOI":"10.1186\/1756-6606-3-11","volume":"3","author":"A Lorenzen","year":"2010","unstructured":"Lorenzen, A. et al. Rapid and direct transport of cell surface app to the lysosome defines a novel selective pathway. Mol. Brain 3, 11 (2010).","journal-title":"Mol. Brain"},{"key":"41545_CR43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-012-1003-7","volume":"124","author":"M Irmler","year":"2012","unstructured":"Irmler, M. et al. Long-term proteasomal inhibition in transgenic mice by UBB(+1) expression results in dysfunction of central respiration control reminiscent of brainstem neuropathology in Alzheimer patients. Acta Neuropathol. 124, 187\u2013197 (2012).","journal-title":"Acta Neuropathol."},{"key":"41545_CR44","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/hmg\/ddg211","volume":"12","author":"H Osaka","year":"2003","unstructured":"Osaka, H. et al. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum. Mol. Genet 12, 1945\u20131958 (2003).","journal-title":"Hum. Mol. Genet"},{"key":"41545_CR45","doi-asserted-by":"crossref","first-page":"36140","DOI":"10.1074\/jbc.M114.557124","volume":"289","author":"P Bishop","year":"2014","unstructured":"Bishop, P., Rubin, P., Thomson, A. R., Rocca, D. & Henley, J. M. The ubiquitin C-terminal hydrolase L1 (UCH-L1) C terminus plays a key role in protein stability, but its farnesylation is not required for membrane association in primary neurons. J. Biol. Chem. 289, 36140\u201336149 (2014).","journal-title":"J. Biol. Chem."},{"key":"41545_CR46","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1073\/pnas.0510403103","volume":"103","author":"C Das","year":"2006","unstructured":"Das, C. et al. Structural basis for conformational plasticity of the Parkinson\u2019s disease-associated ubiquitin hydrolase UCH-L1. Proc. Natl Acad. Sci. USA 103, 4675\u20134680 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"41545_CR47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1042\/BJ20141349","volume":"466","author":"JS Bett","year":"2015","unstructured":"Bett, J. S. et al. Ubiquitin C-terminal hydrolases cleave isopeptide- and peptide-linked ubiquitin from structured proteins but do not edit ubiquitin homopolymers. Biochem. J. 466, 489\u2013498 (2015).","journal-title":"Biochem. J."},{"key":"41545_CR48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(02)01012-7","volume":"111","author":"Y Liu","year":"2002","unstructured":"Liu, Y., Fallon, L., Lashuel, H. A., Liu, Z. & Lansbury, P. T. Jr. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson\u2019s disease susceptibility. Cell 111, 209\u2013218 (2002).","journal-title":"Cell"},{"key":"41545_CR49","volume":"4","author":"M Zhang","year":"2014","unstructured":"Zhang, M., Cai, F., Zhang, S., Zhang, S. & Song, W. Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer\u2019s progression in vivo. Sci. Rep. 4, 7298 (2014).","journal-title":"Sci. Rep."},{"key":"41545_CR50","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2006.06.046","volume":"126","author":"B Gong","year":"2006","unstructured":"Gong, B. et al. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 126, 775\u2013788 (2006).","journal-title":"Cell"},{"key":"41545_CR51","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/j.cell.2022.09.002","volume":"185","author":"Y Yan","year":"2022","unstructured":"Yan, Y. et al. X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women. Cell 185, 3913\u20133930 e3919 (2022).","journal-title":"Cell"},{"key":"41545_CR52","doi-asserted-by":"crossref","first-page":"a006361","DOI":"10.1101\/cshperspect.a006361","volume":"2","author":"Y Ihara","year":"2012","unstructured":"Ihara, Y., Morishima-Kawashima, M. & Nixon, R. The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006361 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"41545_CR53","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41593-022-01084-8","volume":"25","author":"JH Lee","year":"2022","unstructured":"Lee, J. H. et al. Faulty autolysosome acidification in Alzheimer\u2019s disease mouse models induces autophagic build-up of Abeta in neurons, yielding senile plaques. Nat. Neurosci. 25, 688\u2013701 (2022).","journal-title":"Nat. Neurosci."},{"key":"41545_CR54","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.aax3769","volume":"366","author":"C Pohl","year":"2019","unstructured":"Pohl, C. & Dikic, I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science 366, 818\u2013822 (2019).","journal-title":"Science"},{"key":"41545_CR55","volume":"4","author":"YW Zhang","year":"2011","unstructured":"Zhang, Y. W., Thompson, R., Zhang, H. & Xu, H. APP processing in Alzheimer\u2019s disease. Mol. Brain 4, 3 (2011).","journal-title":"Mol. Brain"},{"key":"41545_CR56","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/alz.12546","volume":"18","author":"T Jorda-Siquier","year":"2022","unstructured":"Jorda-Siquier, T. et al. APP accumulates with presynaptic proteins around amyloid plaques: A role for presynaptic mechanisms in Alzheimer\u2019s disease? Alzheimer\u2019s Dement.: J. Alzheimer\u2019s Assoc. 18, 2099\u20132116 (2022).","journal-title":"Alzheimer\u2019s Dement.: J. Alzheimer\u2019s Assoc."},{"key":"41545_CR57","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/aor.14503","volume":"47","author":"JJ Han","year":"2023","unstructured":"Han, J. J. FDA modernization Act 2.0 allows for alternatives to animal testing. Artif. Organs 47, 449\u2013450 (2023).","journal-title":"Artif. Organs"},{"key":"41545_CR58","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41593-018-0175-4","volume":"21","author":"J Park","year":"2018","unstructured":"Park, J. et al. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer\u2019s disease. Nat. Neurosci. 21, 941\u2013951 (2018).","journal-title":"Nat. Neurosci."},{"key":"41545_CR59","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1096\/fj.03-0205com","volume":"17","author":"DF Fischer","year":"2003","unstructured":"Fischer, D. F. et al. Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain. FASEB J. 17, 2014\u20132024 (2003).","journal-title":"FASEB J."},{"key":"41545_CR60","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0002-9440(10)63360-3","volume":"165","author":"T Bussiere","year":"2004","unstructured":"Bussiere, T. et al. Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance. Am. J. Pathol. 165, 987\u2013995 (2004).","journal-title":"Am. J. Pathol."},{"key":"41545_CR61","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1021\/bi052135t","volume":"45","author":"A Case","year":"2006","unstructured":"Case, A. & Stein, R. L. Mechanistic studies of ubiquitin C-terminal hydrolase L1. Biochemistry 45, 2443\u20132452 (2006).","journal-title":"Biochemistry"},{"key":"41545_CR62","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/nprot.2006.4","volume":"1","author":"H Schagger","year":"2006","unstructured":"Schagger, H. Tricine-SDS-PAGE. Nat. Protoc. 1, 16\u201322 (2006).","journal-title":"Nat. Protoc."},{"key":"41545_CR63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneumeth.2010.12.025","volume":"196","author":"KL Youmans","year":"2011","unstructured":"Youmans, K. L. et al. Amyloid-beta42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations. J. Neurosci. Methods 196, 51\u201359 (2011).","journal-title":"J. Neurosci. Methods"},{"key":"41545_CR64","doi-asserted-by":"crossref","first-page":"194936","DOI":"10.1016\/j.bbagrm.2023.194936","volume":"1866","author":"AR Wagh","year":"2023","unstructured":"Wagh, A. R., Sulakshane, P. & Glickman, M. H. Alzheimer\u2019s disease-associated mutant ubiquitin (UBB(+1)) is secreted through an autophagosome-like vesicle-mediated unconventional pathway. Biochim. Biophys. Acta Gene Regul. Mech. 1866, 194936 (2023).","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41545-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41545-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41545-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T15:30:38Z","timestamp":1730129438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41545-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["41545"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-41545-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"assertion":[{"value":"1 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5922"}}